Skip to main content

Multiple Sclerosis

Featured Article
The FDA has rejected anĀ application seeking approval of a key multiple sclerosis drug due to insufficient data.
A recent study examined the impact of an over-the-counter allergy drug on nervous system function in patients with multiple sclerosis.
Back to Top